BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND FLCN, BHD, 201163, ENSG00000154803, MGC23445, MGC17998, FLCL
12 results:

  • 1. Direct regulation of FNIP1 and FNIP2 by MEF2 sustains MTORC1 activation and tumor progression in pancreatic cancer.
    Xia L; Nie T; Lu F; Huang L; Shi X; Ren D; Lu J; Li X; Xu T; Cui B; Wang Q; Gao G; Yang Q
    Autophagy; 2024 Mar; 20(3):505-524. PubMed ID: 37772772
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Phaeochromocytoma in a patient with a Birt-Hogg-Dubé syndrome phenotype.
    Alkundi A; Momoh R
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36997239
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Germline- and Somatic-Inactivating flcn Variants in Parathyroid cancer and Atypical Parathyroid Tumors.
    Jha S; Welch J; Tora R; Lack J; Warner A; Del Rivero J; Sadowski SM; Nilubol N; Schmidt LS; Linehan WM; Weinstein LS; Simonds WF; Agarwal SK
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2686-2698. PubMed ID: 36935552
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. flcn-Driven Functional Adrenal Cortical Carcinoma with High Mitotic Tumor Grade: Extending the endocrine Manifestations of Birt-Hogg-Dubé Syndrome.
    Hofstedter R; Sanabria-Salas MC; Di Jiang M; Ezzat S; Mete O; Kim RH
    Endocr Pathol; 2023 Jun; 34(2):257-264. PubMed ID: 36701047
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Adrenal Cortical Carcinoma and Additional Rare Pathologic Findings in Multi-Organs in a Birt-Hogg-Dubé Syndrome Patient: With an Emphasis on the Molecular Characteristics of Adrenal Cortical Carcinoma.
    Kim D; Murvelashvili N; Hamidi O; Jia L
    Int J Surg Pathol; 2023 Aug; 31(5):689-694. PubMed ID: 35946080
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Primary mediastinal seminoma with leiomyosarcoma: a rare case report.
    Qi Y; Dong C; Cui W; Da L; Li E; Liu Y; Song F
    Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):104-108. PubMed ID: 35818265
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Reconstruction and Exploratory Analysis of mTORC1 Signaling Pathway and Its Applications to Various Diseases Using Network-Based Approach.
    Buddham R; Chauhan S; Narad P; Mathur P
    J Microbiol Biotechnol; 2022 Mar; 32(3):365-377. PubMed ID: 35001007
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Adult rhabdomyoma presenting as thyroid nodule on fine-needle aspiration in patient with Birt-Hogg-Dubé syndrome: Case report and literature review.
    Black M; Wei XJ; Sun W; Simms A; Negron R; Hagiwara M; Chidakel AR; Hodak S; Persky MS; Shi Y
    Diagn Cytopathol; 2020 Jun; 48(6):576-580. PubMed ID: 32187885
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of flcn Detected in Patients With Renal cancer and Thyroid cancer.
    Dong L; Gao M; Hao WJ; Zheng XQ; Li YG; Li XL; Yu Y
    Medicine (Baltimore); 2016 May; 95(22):e3695. PubMed ID: 27258496
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dubé tumour suppressor gene (flcn).
    Lu X; Boora U; Seabra L; Rabai EM; Fenton J; Reiman A; Nagy Z; Maher ER
    Oncogene; 2014 Feb; 33(8):956-65. PubMed ID: 23416984
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Where Birt-Hogg-Dubé meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours.
    Pradella LM; Lang M; Kurelac I; Mariani E; Guerra F; Zuntini R; Tallini G; MacKay A; Reis-Filho JS; Seri M; Turchetti D; Gasparre G
    Eur J Hum Genet; 2013 Oct; 21(10):1169-72. PubMed ID: 23386036
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Germline SDHB mutations and familial renal cell carcinoma.
    Ricketts C; Woodward ER; Killick P; Morris MR; Astuti D; Latif F; Maher ER
    J Natl Cancer Inst; 2008 Sep; 100(17):1260-2. PubMed ID: 18728283
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.